Brief: Vyant Bio And Cyclica Announce A Strategic Collaboration To Identify Compounds To Treat Cdkl5 Deficiency Disorder
19/08/2021 14:40
Aug 19 (Reuters) - Vyant Bio Inc VYNT.O :
* VYANT BIO AND CYCLICA ANNOUNCE A STRATEGIC COLLABORATION
TO
IDENTIFY COMPOUNDS TO TREAT CDKL5 DEFICIENCY DISORDER
Source text for Eikon: ID:nGNX3FmJ1m
Further company coverage: VYNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration